Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Clément Barjon"'
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The tumor immune microenvironment contributes to tumor initiation, progression and response to therapy. Among the immune cell subsets that play a role in the tumor microenvironment, innate-like T cells that express T cell receptors composed of γ and
Externí odkaz:
https://doaj.org/article/885d1086807b4da3b3f6f4b83f15aa0f
Autor:
Claire Lhuillier, Clément Barjon, Valentin Baloche, Toshiro Niki, Aurore Gelin, Rami Mustapha, Laetitia Claër, Sylviane Hoos, Yoichi Chiba, Masaki Ueno, Mitsuomi Hirashima, Ming Wei, Olivier Morales, Bertrand Raynal, Nadira Delhem, Olivier Dellis, Pierre Busson
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202512 (2018)
Extra-cellular galectin-9 (gal-9) is an immuno-modulatory protein with predominant immunosuppressive effects. Inappropriate production of gal-9 has been reported in several human malignancies and viral diseases like nasopharyngeal, pancreatic and ren
Externí odkaz:
https://doaj.org/article/be03e2d39ec746f28578ce32f3a9e63a
Autor:
Clément Barjon, Henri-Alexandre Michaud, Angeline Fages, Cécile Dejou, Alexandre Zampieri, Laetitia They, Aurélie Gennetier, Françoise Sanchez, Laurent Gros, Jean-François Eliaou, Nathalie Bonnefoy, Virginie Lafont
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Vγ9Vδ2 T cells contribute to the immune response against many tumor types through their direct cytotoxic activity and capacity to regulate the biological functions of other immune cells, such as dendritic cells and IFN-γ-producing CD8+ T cells. Ho
Externí odkaz:
https://doaj.org/article/558638ed3e754130a8d2e0ec44e88c32
Autor:
Clément Barjon, Didier Pourquier, Florence Boissière-Michot, Nathalie Bonnefoy, Virginie Lafont, Evelyne Lopez-Crapez, Cécile Dejou, Ghita Chabab, Henri-Alexandre Michaud, William Jacot, Naoill Abdellaoui, Lucie Salvador-Prince
Publikováno v:
Journal of Leukocyte Biology
Journal of Leukocyte Biology, Society for Leukocyte Biology, In press, ⟨10.1002/JLB.3MA0420-278RR⟩
Journal of Leukocyte Biology, Society for Leukocyte Biology, In press, ⟨10.1002/JLB.3MA0420-278RR⟩
γδ T cells contribute to the immune response against many cancers, notably through their powerful effector functions that lead to the elimination of tumor cells and the recruitment of other immune cells. However, their presence in the tumor microen
Autor:
Olivier Scatton, Clément Barjon, Khaldoun Ghazal, Fabien Stenard, Géraldine Dahlqvist, Lynda Aoudjehane, Filomena Conti
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 42:237-244
The mammalian targets of rapamycin (mTOR) inhibitors (sirolimus [SRL] and everolimus [EVR]) are used after transplantation for their immunosuppressive activity. Regulatory T-cells (Tregs) play a crucial role in immune tolerance. mTOR inhibitors appea
Autor:
Géraldine Dahlqvist, Christophe Duvoux, Filomena Conti, François Durand, Clément Barjon, Faouzi Saliba, Lynda Aoudjehane, Khaldoun Ghazal
Publikováno v:
Clinics and research in hepatology and gastroenterology, Vol. 45, no. 5, p. 101559 [1-7] (2021)
Liver transplantation remains the only treatment for terminal liver diseases. However, immunosuppressive drugs required for allograft acceptance are toxic and may be responsible for severe side effects. Modulating the immune system to induce toleranc
Autor:
Géraldine Dahlqvist, Nadira Delhem, Lynda Aoudjehane, Khaldoun Ghazal, Olivier Morales, Clément Barjon, L. Ouaguia, Filomena Conti
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and research in hepatology and gastroenterology, Vol. 43, no.3, p. 273-281 (2019)
Clinics and Research in Hepatology and Gastroenterology, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Clinics and research in hepatology and gastroenterology, Vol. 43, no.3, p. 273-281 (2019)
Clinics and Research in Hepatology and Gastroenterology, 2019, 43, pp.273-281. ⟨10.1016/j.clinre.2018.10.005⟩
Summary Background Immune response failure against hepatitis C virus (HCV) has been associated with an increased regulatory T cell (Treg) activity. After liver transplantation (LT), 80% of patients experience an accelerated progression of hepatitis C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::062a5d10aa7ad4925f5bcd2480a61b7b
https://hal.archives-ouvertes.fr/hal-03486274/document
https://hal.archives-ouvertes.fr/hal-03486274/document
Autor:
Anthony Lefebvre, Sarah Renaud, Geraldine Dahlqvist, Filomena Conti, Yves Horsmans, Nadira Delhem, Lynda Aoudjehane, Clément Barjon
Publikováno v:
Immunobiology
Immunobiology, 2021, 226 (1), pp.152031. ⟨10.1016/j.imbio.2020.152031⟩
Immunobiology, Elsevier, 2021, 226 (1), pp.152031. ⟨10.1016/j.imbio.2020.152031⟩
Immunobiology, Vol. 226, no. 1, p. 152031 [1-9] (2021)
Immunobiology, 2021, 226 (1), pp.152031. ⟨10.1016/j.imbio.2020.152031⟩
Immunobiology, Elsevier, 2021, 226 (1), pp.152031. ⟨10.1016/j.imbio.2020.152031⟩
Immunobiology, Vol. 226, no. 1, p. 152031 [1-9] (2021)
International audience; Background: Immunosuppressive-drugs are needed after solid organ transplantation to prevent allograft rejection but induce severe side effects. Understanding the alloimmune response is critical to modulate it and to achieve gr
Publikováno v:
Digestive and Liver Disease. 47:913-917
Hepatitis C viral infection persists and becomes chronic in a majority of affected individuals. Numerous factors have been described to explain how the virus manages to escape the host immune system. One important escape mechanism is the increase in
Autor:
Claire Lhuillier, Clément Barjon, Valentin Baloche, Toshiro Niki, Aurore Gelin, Rami Mustapha, Laetitia Claër, Sylviane Hoos, Yoichi Chiba, Masaki Ueno, Mitsuomi Hirashima, Ming Wei, Olivier Morales, Bertrand Raynal, Nadira Delhem, Olivier Dellis, Pierre Busson
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2018, 13 (9), pp.e0202512. ⟨10.1371/journal.pone.0202512⟩
PLoS ONE, Vol 13, Iss 9, p e0202512 (2018)
PLoS ONE, Public Library of Science, 2018, 13 (9), pp.e0202512. ⟨10.1371/journal.pone.0202512⟩
PLoS ONE, Vol 13, Iss 9, p e0202512 (2018)
International audience; Extra-cellular galectin-9 (gal-9) is an immuno-modulatory protein with predominant immuno-suppressive effects. Inappropriate production of gal-9 has been reported in several human malignancies and viral diseases like nasophary